vTv Therapeutics Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for vTv Therapeutics.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for VTVT.

Recommendation Trends

Rating	Oct '22	Nov '22	Dec '22	Jan '23	Feb '23
Strong Buy	0	0	0	0	0
Buy	2	2	2	2	2
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Vernon Bernardino HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $240	Strong Buy	Reiterates	$240	+1,664.71%	Mar 7, 2023
Carl Byrnes Northland Capital Markets	Northland Capital Markets	Buy Maintains $60 → $80	Buy	Maintains	$60 → $80	+488.24%	Aug 17, 2022
Charles Duncan Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates $200	Buy	Initiates	$200	+1,370.59%	Feb 18, 2022
Vernon Bernardino HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $200 → $240	Strong Buy	Reiterates	$200 → $240	+1,664.71%	Feb 10, 2020
Vernon Bernardino HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $200	Strong Buy	Initiates	$200	+1,370.59%	May 30, 2019

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-0.34

from -9.71

EPS Next Year

n/a

from -0.34

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Revenue	2.76M	6.41M	4.01M	2.02M	-	-
Revenue Growth	-77.77%	132.05%	-37.56%	-49.61%	-	-
EPS	-23.65	-7.21	-8.29	-9.98	-9.71	-0.34
EPS Growth	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2024
High	-
Avg	-
Low	-

EPS Forecast

EPS	2024
High	-0.35
Avg	-0.34
Low	-0.32

EPS Growth

EPS Growth	2024
High	-
Avg	-
Low	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.